Experimental studies have shown that blocking IL-17 signaling (e.g., with an Adeno-IL17R:Fc vector) reduces lymphocyte infiltrate and enhances salivary secretion in mouse models of SS [123], confirming the pathogenetic importance of IL-17A. This evidence concerns the gene IL17A and synovial sarcoma.